These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1826112)

  • 1. Spironolactone in dermatologic therapy.
    Shaw JC
    J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):236-43. PubMed ID: 1826112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spironolactone therapy in hirsutism and acne.
    Callan AW
    Australas J Dermatol; 1988; 29(3):135-9. PubMed ID: 2978784
    [No Abstract]   [Full Text] [Related]  

  • 3. Tolerance of spironolactone.
    Hughes BR; Cunliffe WJ
    Br J Dermatol; 1988 May; 118(5):687-91. PubMed ID: 2969259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Brown J; Farquhar C; Lee O; Toomath R; Jepson RG
    Cochrane Database Syst Rev; 2009 Apr; (2):CD000194. PubMed ID: 19370553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of spironolactone in dermatology.
    Rathnayake D; Sinclair R
    Skinmed; 2010; 8(6):328-32; quiz 333. PubMed ID: 21413648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral and topical spironolactone therapies in skin androgenization.
    Messina M; Manieri C; Musso MC; Pastorino R
    Panminerva Med; 1990; 32(2):49-55. PubMed ID: 2147469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spironolactone in dermatology.
    Cunliffe WJ
    J Am Acad Dermatol; 1992 Jan; 26(1):137-8. PubMed ID: 1531055
    [No Abstract]   [Full Text] [Related]  

  • 8. Spironolactone in dermatology: uses in acne and beyond.
    Searle TN; Al-Niaimi F; Ali FR
    Clin Exp Dermatol; 2020 Dec; 45(8):986-993. PubMed ID: 32844462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Farquhar C; Lee O; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2003; (4):CD000194. PubMed ID: 14583916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indications and limits of anti-androgen therapy].
    Zaun H
    Z Hautkr; 1984 Aug; 59(16):1090-7. PubMed ID: 6207673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Farquhar C; Lee O; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2001; (4):CD000194. PubMed ID: 11687072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Lee O; Farquhar C; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2000; (2):CD000194. PubMed ID: 10796700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia.
    Burke BM; Cunliffe WJ
    Br J Dermatol; 1985 Jan; 112(1):124-5. PubMed ID: 3155956
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiandrogens in the treatment of acne and hirsutism.
    Jurzyk RS; Spielvogel RL; Rose LI
    Am Fam Physician; 1992 Apr; 45(4):1803-6. PubMed ID: 1532683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The therapeutic effect of spironolactone in the hyperandrogenism syndrome].
    Shilin DE; Dedov II; Grigor'eva EA
    Probl Endokrinol (Mosk); 1993; 39(2):55-60. PubMed ID: 8016057
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of hirsutism with spironolactone and progestagen combination].
    Pugeat M; Elmidani M; Dechaud H; Garoscio-Cholet M; Lejeune H; Tourniaire J
    Presse Med; 1990 Oct; 19(33):1529-32. PubMed ID: 2146664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spironolactone in dermatological treatment. On and off label indications].
    Salavastru CM; Fritz K; Tiplica GS
    Hautarzt; 2013 Oct; 64(10):762-7. PubMed ID: 24150826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose spironolactone in the treatment of female hirsutism.
    Ylöstalo P; Heikkinen J; Kauppila A; Pakarinen A; Järvinen PA
    Int J Fertil; 1987; 32(1):41-5. PubMed ID: 2880814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral spironolactone improves acne vulgaris and reduces sebum excretion.
    Goodfellow A; Alaghband-Zadeh J; Carter G; Cream JJ; Holland S; Scully J; Wise P
    Br J Dermatol; 1984 Aug; 111(2):209-14. PubMed ID: 6235834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spironolactone in Dermatology: Uses in Acne, Hidradenitis Suppurativa, Female Pattern Baldness, and Hirsutism.
    Vargas-Mora P; Morgado-Carrasco D
    Actas Dermosifiliogr (Engl Ed); 2020 Oct; 111(8):639-649. PubMed ID: 32571540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.